Clinical trial
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary…
NCT00386334 · Sumitomo Pharma America, Inc., Industry · Completed
Key facts
| NCT number | NCT00386334 |
|---|---|
| Title | A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia |
| Official title | A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia |
| Lead sponsor | Sumitomo Pharma America, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | Eszopiclone, Placebo |
| Enrollment | 388 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Oct 11, 2006 |
| Last update posted | Mar 14, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: